Axsome Therapeutics, Inc.

NASDAQ:AXSM

Biotechnology

Healthcare
$134.00 +0.10%

+$0.25 today

Market cap
$7.05B
Beta
0.60
P/E (TTM)
-68.6
EPS (TTM)
-$3.68
52W Low $96.09High $257.93

Volume 0.74M

Average 0.72M

AXSM Pre-Tax Margin

Income before tax as a percentage of revenue.

Axsome Therapeutics, Inc.NASDAQ: AXSM

Pre-Tax Margin · Q2 FY2026 · quarter ended Jun 2026

Pre-tax margin widens to -23.4%

Pre-tax margin was -23.4% in Q2 FY2026, up 9.2 pp from a year earlier. On a trailing-twelve-month basis it was -24.6%, up 25.4 pp year over year. Over 3 fiscal years it widened by 345.2 pp.

Context

  • Pre-tax margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
-23.4%+10.3 pp QoQ
Last fiscal yearDec 2025
-28.8%+45.7 pp YoY
LTMJun 2026
-24.6%+25.4 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+9.2 pp——
1 year+45.7 pp——
3 years+345.2 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
-28.8%
Year-over-year change
+45.7pp

Pre-Tax Margin vs competitors

How AXSM compares with its peers on the latest reported figures

  • AXSM's LTM Jun 2026 pre-tax margin of -24.6% is the 4th highest of the 7 companies compared; the peer median is -275.6%.
  • Its year-over-year change of +25.4 pp is the highest of 4, against a peer median of +1.7 pp.
  • Over three fiscal years its change of +345.2 pp compares with a peer median of -10.1 pp.
AXSM Competitors Peer median
Pre-Tax Margin for AXSM and competitors
Company Period LTM level YoY 3-year change
NBIXNeurocrine Biosciences, Inc.LTM Sep 202625.2% +1.7 pp+10.3 pp
JAZZJazz Pharmaceuticals plcLTM Sep 20265.5% +22.4 pp-4.3 pp
SUPNSupernus Pharmaceuticals, Inc.LTM Jun 2026-14.9% -27.2 pp-15.9 pp
AXSMAxsome Therapeutics, Inc.LTM Jun 2026-24.6% +25.4 pp+345.2 pp
RAPPRapport Therapeutics, Inc. Common StockLTM Mar 2026-536.4% ——
XENEXenon Pharmaceuticals Inc.FY2025-4598.6% —-3270.9 pp
DNLIDenali Therapeutics Inc.LTM Jun 2026-14188.4% ——
PRAXPraxis Precision Medicines, Inc.FY2025— ——
DFTXDefinium Therapeutics, Inc.FY2025— ——
AVXLAnavex Life Sciences Corp.FY2025— ——
NMRANeumora Therapeutics, Inc. Common StockFY2025— ——
Peer median (excluding AXSM) -275.6%+1.7 pp-10.1 pp

Competitors are the stored peer set for AXSM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue050.04M270.6M385.69M638.5M
Cost of Revenue05.2M26.07M33.3M47.48M
Gross Profit044.84M244.54M352.39M591.02M
Gross Margin—89.6%90.4%91.4%92.6%
Research & Development58.06M57.95M97.94M187.08M183.28M
Selling, General & Admin66.65M159.25M323.12M411.36M570.6M
Operating Expenses124.71M224.64M476.36M632.95M760.25M
Depreciation & Amortization76K4.4M6.83M7.96M9.06M
EBITDA(124.63M)(175.4M)(224.99M)(272.6M)(168.08M)
EBITDA Margin—-350.5%-83.1%-70.7%-26.3%
Operating Income(124.71M)(179.8M)(231.83M)(280.56M)(169.24M)
Operating Margin—-359.3%-85.7%-72.7%-26.5%
Interest Income00009.37M
Interest Expense5.7M7.34M6.45M6.57M6.56M
Other Income / Expenses(5.7M)(7.34M)(6.45M)(6.57M)(14.47M)
Income Before Tax(130.4M)(187.13M)(238.28M)(287.13M)(183.7M)
Pre-Tax Margin—-374.0%-88.1%-74.4%-28.8%
Income Tax Expense00960K85K(530K)
Net Income(130.4M)(187.13M)(239.24M)(287.22M)(183.17M)
Net Margin—-374.0%-88.4%-74.5%-28.7%
EPS (Basic)(3.47)(4.60)(5.27)(5.99)(3.68)
EPS (Diluted)(3.47)(4.60)(5.27)(5.99)(3.68)
Weighted Avg Shares37.62M40.66M45.43M47.91M49.75M
Weighted Avg Shares (Diluted)37.62M40.66M45.43M47.91M49.75M

Axsome Therapeutics, Inc.

NASDAQ:AXSM

Intrinsic Alpha fair value

Locked

Current Price

$134.00

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.